Crossmark

Safety and efficacy of a pre-phase with dexamethasone followed by fractionated R-CHOP in diffuse large B-cell lymphoma patients with gastrointestinal involvement at diagnosis

Crossref DOI link: https://doi.org/10.1007/s00277-026-06824-5

Published Online: 2026-01-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cui, Ke

Wan, Jiangbo

Li, Zhichao

Zhao, Jie

Qin, Yun

Hao, Siguo

Huang, Fang
Funding

Funding for this research was provided by:

the Medical Industrial Crossroads Research Fund from Shanghai Jiaotong University (No. YG2024QNB12)

Clinical Innovation Project from Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine (No.23XHCR22C)
License Information

Text and Data Mining valid from 2026-01-23

Version of Record valid from 2026-01-23
More Information

Article History

Received: 30 October 2025

Accepted: 7 January 2026

First Online: 23 January 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below